Alto Neuroscience ANRO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's free cash flow?
- Alto Neuroscience (ANRO) reported free cash flow of -$27.65M in Q1 2026.
- How has Alto Neuroscience's free cash flow changed year-over-year?
- Alto Neuroscience's free cash flow decreased by 66.7% year-over-year, from -$16.58M to -$27.65M.
- What is the long-term trend for Alto Neuroscience's free cash flow?
- Over 2 years (2023 to 2025), Alto Neuroscience's free cash flow has grown at a 23.6% compound annual growth rate (CAGR), from -$33.92M to -$51.79M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.